These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33647170)

  • 1. DEFB1 gene polymorphisms modify vitiligo extent and response to NB-UVB phototherapy.
    Salem RM; Abdelrahman AMN; Abd El-Kareem HM; Seif M
    Dermatol Ther; 2021 May; 34(3):e14921. PubMed ID: 33647170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human beta-defensin 1 circulating level and gene polymorphism in non-segmental vitiligo Egyptian patients.
    Farag AGA; Shoeib MAA; Labeeb AZ; Sleem AS; Khallaf HMA; Khalifa AS; Elshaib ME; Elnaidany NF; Hanout HMA
    An Bras Dermatol; 2023; 98(2):181-188. PubMed ID: 36535830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment outcome and persistence of repigmentation from narrow-band ultraviolet B phototherapy in vitiligo.
    Silpa-Archa N; Weerasubpong P; Junsuwan N; Yothachai P; Supapueng O; Wongpraparut C
    J Dermatolog Treat; 2019 Nov; 30(7):691-696. PubMed ID: 30474443
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of vitamin D receptor gene polymorphisms (ApaI and TaqI) as risk factors of vitiligo and predictors of response to narrowband UVB phototherapy.
    Youssef YE; Eldegla HEA; Elmekkawy RSM; Gaballah MA
    Arch Dermatol Res; 2023 Apr; 315(3):379-386. PubMed ID: 35318513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
    Tawfik YM; Abd Elazim NE; Abdel-Motaleb AA; Mohammed RAA; Tohamy AMA
    J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-body and targeted narrowband ultraviolet B phototherapy effectively stabilize acral vitiligo with negligible repigmentation beyond wrists and ankles: Results from a split-body randomized controlled trial.
    Thind A; Vinay K; Mehta H; Bishnoi A; Kumaran MS; Parsad D
    Photodermatol Photoimmunol Photomed; 2024 Mar; 40(2):e12960. PubMed ID: 38480997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of interrupted versus continuous narrowband ultraviolet B phototherapy in nonsegmental vitiligo treatment: A prospective randomized comparative study.
    Anbar TS; Mohammed SS; Mohamed DM; Abdel-Rahman AT
    Dermatol Ther; 2019 Nov; 32(6):e13117. PubMed ID: 31606939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics and decreased Vitiligo Area Scoring Index of vitiligo patients with narrowband-UVB phototherapy in Yogyakarta, Indonesia.
    Pradipta NK; Ryoto V; Danarti R; Budiyanto A
    Dermatol Reports; 2023 Dec; 15(4):9708. PubMed ID: 38205424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Narrowband ultraviolet B phototherapy combined with intralesional injection of either latanoprost or platelet-rich plasma for stable nonsegmental vitiligo.
    Fawzy M; Al-Mokadem S; Alshereef M; Elkholy B
    Photodermatol Photoimmunol Photomed; 2024 Jan; 40(1):e12929. PubMed ID: 37984828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study on efficacy of UVA1 vs. narrow-band UVB phototherapy in the treatment of vitiligo.
    El-Zawahry BM; Bassiouny DA; Sobhi RM; Abdel-Aziz E; Zaki NS; Habib DF; Shahin DM
    Photodermatol Photoimmunol Photomed; 2012 Apr; 28(2):84-90. PubMed ID: 22409711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of human beta-defensin 1 gene polymorphisms with nonsegmental vitiligo.
    Ochoa-Ramírez LA; Becerra-Loaiza DS; Díaz-Camacho SP; Muñoz-Estrada VF; Ríos-Burgueño ER; Prado-Montes de Oca E; Rangel-Villalobos H; Velarde-Félix JS
    Clin Exp Dermatol; 2019 Apr; 44(3):277-282. PubMed ID: 29923320
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative study on the use of fractional CO
    Bakr RM; Abdel-Gaber RM; Tawfik YM
    Dermatol Ther; 2021 Jan; 34(1):e14604. PubMed ID: 33249712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of narrow-band ultraviolet B on the serum of 25-hydroxyvitamin D in vitiligo patients.
    Ibrahim H; El Taieb M; El Gamel Z; El Saied AR
    J Cosmet Dermatol; 2018 Oct; 17(5):911-916. PubMed ID: 29524288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of combined microneedling and narrowband ultraviolet B phototherapy versus their combination with topical latanoprost in the treatment of vitiligo.
    Neinaa YME; Lotfy SS; Ghaly NR; Doghaim NN
    Dermatol Ther; 2021 Mar; 34(2):e14813. PubMed ID: 33497514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative interventional study of narrowband ultraviolet B alone and narrowband ultraviolet B in combination with microneedling in patients with stable vitiligo.
    Kaur A; Barman KD; Sahoo B; Choudhary P
    Photodermatol Photoimmunol Photomed; 2023 Jul; 39(4):357-363. PubMed ID: 36419200
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficacy between localized 308-nm excimer light and targeted 311-nm narrowband ultraviolet B phototherapy in vitiligo: A randomized, single-blind comparison study.
    Poolsuwan P; Churee C; Pattamadilok B
    Photodermatol Photoimmunol Photomed; 2021 Mar; 37(2):123-130. PubMed ID: 33047405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index.
    Hamzavi I; Jain H; McLean D; Shapiro J; Zeng H; Lui H
    Arch Dermatol; 2004 Jun; 140(6):677-83. PubMed ID: 15210457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a preceding fractional carbon dioxide laser on the outcome of combined local narrowband ultraviolet B and topical steroids in patients with vitiligo in difficult-to-treat areas.
    Vachiramon V; Chaiyabutr C; Rattanaumpawan P; Kanokrungsee S
    Lasers Surg Med; 2016 Feb; 48(2):197-202. PubMed ID: 26175036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination treatment by 10 600 nm ablative fractional carbon dioxide laser and narrowband ultraviolet B in refractory nonsegmental vitiligo: a prospective, randomized half-body comparative study.
    Shin J; Lee JS; Hann SK; Oh SH
    Br J Dermatol; 2012 Mar; 166(3):658-61. PubMed ID: 22050270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NB-UVB plus oral Polypodium leucotomos extract display higher efficacy than NB-UVB alone in patients with vitiligo.
    Pacifico A; Damiani G; Iacovelli P; Conic RRZ; ; Gonzalez S; Morrone A
    Dermatol Ther; 2021 Mar; 34(2):e14776. PubMed ID: 33433041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.